Changes in inflammatory markers, including PCT and WBC, did not reach statistical significance, although a trend toward lower PCT levels was observed in patients managed with TDM.
← all excerpts
Practical utility of meropenem therapeutic drug monitoring: a systematic review of evidence for clinical application.
1
—
—